4Kaner T, Sasani M, Oktenoglu T, et al. Clinical analysis of 21 cases of spinal cord ependymoma: positive clinical results of gross total resection [J]. J Korean Neurosurg Soc, 2010, 47(2): 102-106.
5Joaquim AF, Santos M J, Tedeschi H. Surgical management of intramedullary spinal ependymomas [J]. Arq Neuropsi- quiatr, 2009, 67(2A): 284-289.
6Kelleher MO, Tan G, Sarjeant R, et al. Predictive value of intraoperative neurophysiological monitoring during cervical spine surgery: a prospective analysis of 1 055 consecutive patients [J]. J Neurosurg Spine, 2008, 8(3): 215-221.
7Kim WH, Yoon SH, Kim CY, et al. Temozolomide for malig- nant primary spinal cord glioma: an experience of six cases and a literature review [J]. J Neurooncol, 2011, 101(2): 247- 254.
8Freyschlag CF, Tuettenberg J, Lohr F, et al. Response to temozolomide in supratentorial muhifocal recurrence of malignant ependymoma [J]. Anticancer Res, 2011, 31(3): 1023-1025.
9Asazuma T, Nakamura M, Matsumoto M, et al. Postoperative changes of spinal curvature and range of motion in adult patients with cervical spinal cord tumors: analysis of 51 cases and review of the literature [J]. J spinal Disord Tech, 2004, 17(3): 178-182.
10Lin YH, Huang CI, Wong TT, et al. Treatment of spinal cord ependymomas by surgery with or without postoperative ra- diotherapy [J]. J Neurooncol, 2005, 71(2): 205-210.
